Specialty Chemicalsworld trade 2024+2.3% 5Y CAGR
Oct 15, 2018ACQUISITIONUnited States Cambrex acquires Halo Pharma from SK Capital for $425 million
Cambrex acquired Halo Pharma, a contract development and manufacturing organization, from SK Capital in Q3 2018 for $425 million.
Productscontract development and manufacturing
“Chemical Deal Results | Seller | Buyer | Business | Date |”everchem.com
- 2 sources
- everchem.comQ3 M&A Update - Everchem Specialty ChemicalsOct 15, 2018
- everchem.comQ3 M&A Update - Everchem Specialty ChemicalsOct 15, 2018
Summarized from public sources; check the original articles before acting on it.